Paul Y. Song
Amministratore Delegato presso NKGen Biotech, Inc.
Patrimonio netto: 284 409 $ in data 31/05/2024
Posizioni attive di Paul Y. Song
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
NKGen Biotech, Inc.
 NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA. | Presidente | - | - |
| Amministratore Delegato | 10/01/2023 | - | |
| Direttore/Membro del Consiglio | - | - | |
| Direttore Tecnico/Scientifico/R&S | - | 10/01/2023 | |
PeproMene Bio, Inc.
 PeproMene Bio, Inc. Pharmaceuticals: MajorHealth Technology PeproMene Bio, Inc. engages in developing novel immune-oncology therapies. The company was founded in 2016 and is headquartered in Irvine, CA. | Direttore/Membro del Consiglio | 01/03/2022 | - |
Mercy Corps
 Mercy Corps Services to the Health IndustryHealth Services Mercy Corps provides emergency relief and economic support services. The company makes a real impact in the lives of families in the world’s toughest places. The company was founded by Daninel W. O'Neill and Ellsworth Culver in November 1979 and is headquartered in Portland, OR. | Direttore/Membro del Consiglio | - | - |
| Gideons Promise, Inc. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Paul Y. Song
Precedenti posizioni note di Paul Y. Song
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Fuse Biotherapeutics, Inc.
 Fuse Biotherapeutics, Inc. BiotechnologyHealth Technology Fuse Biotherapeutics, Inc. is a biotechnology company based in Los Angeles, CA. Fuse Biotherapeutics is dedicated to developing transformative immune modulating therapeutics for patients with cancer. The company's therapeutic approach integrates the multiple steps of an immune response in a rational manner that targets potent responses to danger without sacrificing natural breaks in the system that spare healthy tissues. The company was founded by Jeffrey Kunio Takimoto, Geoffrey W. Smith, Y Song Paul, Evren Alici, Brian Rabinovich. | Direttore/Membro del Consiglio | 01/06/2021 | 01/01/2023 |
| Amministratore Delegato | 01/06/2021 | 01/01/2023 | |
| Fondatore | 01/06/2021 | 01/01/2023 | |
| NKMAX CO., LTD. | Direttore Tecnico/Scientifico/R&S | 01/03/2016 | 01/01/2021 |
Formazione di Paul Y. Song
| The University of Chicago | Undergraduate Degree |
| George Washington University School of Medicine & Health | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 8 |
| Corea del Sud | 2 |
Posizioni
| Director/Board Member | 6 |
| Chief Executive Officer | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
Settori
| Health Technology | 5 |
| Consumer Services | 3 |
| Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| NKMAX CO., LTD. | Health Technology |
| Aziende private | 5 |
|---|---|
Mercy Corps
Mercy Corps Services to the Health IndustryHealth Services Mercy Corps provides emergency relief and economic support services. The company makes a real impact in the lives of families in the world’s toughest places. The company was founded by Daninel W. O'Neill and Ellsworth Culver in November 1979 and is headquartered in Portland, OR. | Health Services |
PeproMene Bio, Inc.
PeproMene Bio, Inc. Pharmaceuticals: MajorHealth Technology PeproMene Bio, Inc. engages in developing novel immune-oncology therapies. The company was founded in 2016 and is headquartered in Irvine, CA. | Health Technology |
NKGen Biotech, Inc.
NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA. | Health Technology |
Fuse Biotherapeutics, Inc.
Fuse Biotherapeutics, Inc. BiotechnologyHealth Technology Fuse Biotherapeutics, Inc. is a biotechnology company based in Los Angeles, CA. Fuse Biotherapeutics is dedicated to developing transformative immune modulating therapeutics for patients with cancer. The company's therapeutic approach integrates the multiple steps of an immune response in a rational manner that targets potent responses to danger without sacrificing natural breaks in the system that spare healthy tissues. The company was founded by Jeffrey Kunio Takimoto, Geoffrey W. Smith, Y Song Paul, Evren Alici, Brian Rabinovich. | Health Technology |
| Gideons Promise, Inc. |
- Borsa valori
- Insiders
- Paul Y. Song
- Esperienza
